Enzon Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 74   

Articles published

ENZN 1.07 -0.01 (-0.93%)
price chart
Enzon Pharmaceuticals Inc (ENZN): Warning! Enzon Pharmaceuticals Is ...
Finance profile for the company! Right off the bat, that doesn't give us a lot of confidence, now does it? Enzon Pharmaceuticals (NASDAQ:ENZN) used to be a research stage biotech firm, focusing on a technology known as PEGylation. PEGylation was used ...
Enzon Pharmaceuticals Inc Stock Upgraded (ENZN)
This is a signal of significant strength within the corporation. Compared to other companies in the Biotechnology industry and the overall market, ENZON PHARMACEUTICALS INC's return on equity significantly exceeds that of both the industry average and ...
Enzon Pharmaceuticals, Inc. (ENZN) Ex-Dividend Date Scheduled for December ...
will begin trading ex-dividend on December 24, 2013. A cash dividend payment of $0.45 per share is scheduled to be paid on December 23, 2013.
Related articles »  
Receptos Inc, Enzon Pharmaceuticals Inc Soar Midday
Receptos Inc (NASDAQ:RCPT), Enzon Pharmaceuticals Inc (NASDAQ:ENZN) and Applied Micro Circuits Corporation (NASDAQ:AMCC) are this Tuesday's top gainers midday.
Enzon Pharmaceuticals, Inc. (ENZN): Are Hedge Funds Right About This Stock?
Is Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) a buy, sell, or hold? The best stock pickers are taking a bearish view.
Enzon Pharmaceuticals sells Indy drug plant; 100 local jobs safe
Orphan drugs, as they're known in the pharmaceutical industry, treat diseases that afflict fewer than 200,000 patients in the United States.
Related articles »  
Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes ...
On Friday, shares in Enzon Pharmaceuticals Inc. fluctuated between $1.08 and $1.29 before ending the session 14.29% lower at $1.08.
Related articles »  
Enzon Pharmaceuticals, Inc. (ENZN): Insiders Aren't Crazy About It
Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) was in 15 hedge funds' portfolio at the end of the first quarter of 2013.
Biotech News Bundle: Protalix BioTherapeutics (PLX), Enzon Pharmaceuticals ...
Protalix BioTherapeutics Inc. (NYSEMKT:PLX) jumped 8.30% after news that the company Pfizer Inc. (NYSE:PFE) declared that the U.S.
Related articles »  
Stock Runners: Enzon Pharmaceuticals Inc. (ENZN), GoPro, Inc. (GPRO ...
Enzon Pharmaceuticals Inc. (NASDAQ:ENZN)'s stock was upgraded by investment analysts at TheStreet from a �sell� rating to a �hold� rating in a note issued to investors on July 8. The analysts wrote, �Enzon Pharmaceuticals (ENZN) has been upgraded by ...